Glover G I, Schasteen C S, Liu W S, Levine R P
Biological Sciences Department, Monsanto Company, St. Louis, MO 63198.
Mol Immunol. 1988 Dec;25(12):1261-7. doi: 10.1016/0161-5890(88)90040-5.
Sequence homology comparisons between serum serine protease inhibitors led to the prediction that the C-terminal sequences are functionally equivalent and represent an essential protease binding domain. Inhibition of complement serine protease D cleavage of factor B and of C1s cleavage of C4 by synthetic peptides containing sequences from the C-termini of three serum serine protease inhibitors supports this prediction. These functionally equivalent peptides represent a new class of inhibitors of D and C1s as well as other serum serine proteases.
血清丝氨酸蛋白酶抑制剂之间的序列同源性比较表明,其C端序列在功能上是等效的,代表一个必需的蛋白酶结合结构域。含有三种血清丝氨酸蛋白酶抑制剂C端序列的合成肽对补体丝氨酸蛋白酶D裂解因子B以及C1s裂解C4的抑制作用支持了这一预测。这些功能等效的肽代表了一类新型的D和C1s以及其他血清丝氨酸蛋白酶的抑制剂。